Abstract
To maintain lifelong production of blood cells, haematopoietic stem cells (HSCs) are tightly regulated by inherent programs and extrinsic regulatory signals received from their microenvironmental niche. Long-term repopulating HSCs reside in several, perhaps overlapping, niches that produce regulatory molecules and signals necessary for homeostasis and for increased output after stress or injury1,2,3,4,5. Despite considerable advances in the specific cellular or molecular mechanisms governing HSC–niche interactions, little is known about the regulatory function in the intact mammalian haematopoietic niche. Recently, we and others described a positive regulatory role for prostaglandin E2 (PGE2) on HSC function ex vivo6,7. Here we show that inhibition of endogenous PGE2 by non-steroidal anti-inflammatory drug (NSAID) treatment in mice results in modest HSC egress from the bone marrow. Surprisingly, this was independent of the SDF-1–CXCR4 axis implicated in stem-cell migration. Stem and progenitor cells were found to have differing mechanisms of egress, with HSC transit to the periphery dependent on niche attenuation and reduction in the retentive molecule osteopontin. Haematopoietic grafts mobilized with NSAIDs had superior repopulating ability and long-term engraftment. Treatment of non-human primates and healthy human volunteers confirmed NSAID-mediated egress in other species. PGE2 receptor knockout mice demonstrated that progenitor expansion and stem/progenitor egress resulted from reduced E-prostanoid 4 (EP4) receptor signalling. These results not only uncover unique regulatory roles for EP4 signalling in HSC retention in the niche, but also define a rapidly translatable strategy to enhance transplantation therapeutically.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies
Stem Cell Research & Therapy Open Access 29 May 2021
-
A novel small molecule CXCR4 antagonist potently mobilizes hematopoietic stem cells in mice and monkeys
Stem Cell Research & Therapy Open Access 07 January 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003)
Ding, L., Saunders, T. L., Enikolopov, G. & Morrison, S. J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457–462 (2012)
Méndez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829–834 (2010)
Raaijmakers, M. H. et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464, 852–857 (2010)
Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836–841 (2003)
Hoggatt, J., Singh, P., Sampath, J. & Pelus, L. M. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113, 5444–5455 (2009)
North, T. E. et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007–1011 (2007)
Ahmed, M., Khanna, D. & Furst, D. E. Meloxicam in rheumatoid arthritis. Expert Opin. Drug Metab. Toxicol. 1, 739–751 (2005)
Rinder, H. M. et al. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial. J. Clin. Pharmacol. 42, 881–886 (2002)
Breyer, R. M., Bagdassarian, C. K., Myers, S. A. & Breyer, M. D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661–690 (2001)
Katayama, Y. et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407–421 (2006)
Bethel, M., Srour, E. F. & Kacena, M. A. Hematopoietic cell regulation of osteoblast proliferation and differentiation. Curr. Osteoporos. Rep. 9, 96–102 (2011)
Hoggatt, J. & Pelus, L. M. Many mechanisms mediating mobilization: an alliterative review. Curr. Opin. Hematol. 18, 231–238 (2011)
Mundy, G. R., Yoneda, T. & Hiraga, T. Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment. Semin. Oncol. 28, 35–44 (2001)
Winkler, I. G. et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815–4828 (2010)
Chow, A. et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261–271 (2011)
Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R. & Link, D. C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251–260 (2011)
Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 109, 625–637 (2002)
Chitteti, B. R. et al. Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function. Blood 115, 3239–3248 (2010)
Nakamura, Y. et al. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 116, 1422–1432 (2010)
Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781–1791 (2005)
Grassinger, J. et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with α9β1 and α4β1 integrins. Blood 114, 49–59 (2009)
Nie, Y. et al. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200, 1145–1156 (2004)
Kennedy, C. R. et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nature Med. 5, 217–220 (1999)
Guan, Y. et al. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J. Clin. Invest. 117, 2496–2505 (2007)
Schneider, A. et al. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 40, 7–14 (2004)
Mignone, J. L., Kukekov, V., Chiang, A. S., Steindler, D. & Enikolopov, G. Neural stem and progenitor cells in nestin-GFP transgenic mice. J. Comp. Neurol. 469, 311–324 (2004)
Kalajzic, Z. et al. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 31, 654–660 (2002)
Chen, X. S., Sheller, J. R., Johnson, E. N. & Funk, C. D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372, 179–182 (1994)
King, A. G. et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROβ. Blood 97, 1534–1542 (2001)
Pelus, L. M., Broxmeyer, H. E., Kurland, J. I. & Moore, M. A. Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J. Exp. Med. 150, 277–292 (1979)
Broxmeyer, H. E. et al. SDF-1/CXCL12 enhances in vitro replating capacity of murine and human multipotential and macrophage progenitor cells. Stem Cells Dev. 16, 589–596 (2007)
Fukuda, S., Bian, H., King, A. G. & Pelus, L. M. The chemokine GROβ mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 110, 860–869 (2007)
Hoggatt, A. F., Hoggatt, J., Honerlaw, M. & Pelus, L. M. A spoonful of sugar helps the medicine go down: a novel technique to improve oral gavage in mice. J. Am. Assoc. Lab. Anim. Sci. 49, 329–334 (2010)
Sutherland, D. R., Anderson, L., Keeney, M., Nayar, R. & Chin-Yee, I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J. Hematother. 5, 213–226 (1996)
Mohammad, K. S. et al. Pharmacologic inhibition of the TGF-β type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS ONE 4, e5275 (2009)
Rowe, P. S. et al. Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin. Bone 39, 773–786 (2006)
Parfitt, A. M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595–610 (1987)
Murali, G. et al. Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR−/− mice. J. Lipid Res. 53, 2186–2197 (2012)
Liu, T. et al. Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation. Proc. Natl Acad. Sci. USA 109, 12692–12697 (2012)
Acknowledgements
These studies were supported by National Institutes of Health (NIH) grants HL096305 (L.M.P.), CA143057, CA069158 (T.A.G., K.S.M.), HL100402 (D.T.S.) and DK37097 (R.M.B.). J.H. was supported by NIH training grants DK07519, HL07910 and HL087735. Flow cytometry was performed in the Flow Cytometry Resource Facility of the Indiana University Simon Cancer Center (NCI P30 CA082709). Additional core support was provided by a Center of Excellence in Hematology grant P01 DK090948. The authors would like to thank H. E. Broxmeyer and B. Saez for critically reading the manuscript.
Author information
Authors and Affiliations
Contributions
All authors assisted in writing of the manuscript. J.H. analysed data, wrote the manuscript, designed all experiments and implemented all experiments with assistance from P.S., A.F.H., B.R.C., J.M.S., P.H., B.A.P., K.N.S., F.F., L.S. and F.K.W. K.S.M., M.C. and T.A.G. performed histological analyses and assisted with corresponding study designs. G.L.M. and R.M.B. performed eicosanoid analysis and generated E-prostanoid receptor knockout mice, and C.H.S. assisted with Alox5 mice and experiments. D.T.S. and E.F.S. assisted with experimental design and data analyses. L.M.P. designed and performed experiments, analysed and evaluated all data, and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
J.H. and L.M.P. have filed patent applications based on these findings.
Supplementary information
Supplementary Figures
This file contains Supplementary Figures 1-23. (PDF 1587 kb)
Rights and permissions
About this article
Cite this article
Hoggatt, J., Mohammad, K., Singh, P. et al. Differential stem- and progenitor-cell trafficking by prostaglandin E2. Nature 495, 365–369 (2013). https://doi.org/10.1038/nature11929
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature11929
This article is cited by
-
Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases
European Journal of Clinical Nutrition (2023)
-
CD14 positive cells accelerate hematopoietic stem cell engraftment
Bone Marrow Transplantation (2022)
-
Upregulation of SIRT1 Contributes to dmPGE2-dependent Radioprotection of Hematopoietic Stem Cells
Stem Cell Reviews and Reports (2022)
-
Tissue Engineering with Compact Bone-Derived Cell Spheroids Enables Bone Formation around Transplanted Tooth
Tissue Engineering and Regenerative Medicine (2022)
-
A novel small molecule CXCR4 antagonist potently mobilizes hematopoietic stem cells in mice and monkeys
Stem Cell Research & Therapy (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.